131 related articles for article (PubMed ID: 28521468)
1. Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.
Ishii N; Araki K; Yokobori T; Watanabe A; Tsukagoshi M; Kubo N; Suzuki H; Saito F; Altan B; Hosouchi Y; Shirabe K; Kuwano H
Oncol Lett; 2017 May; 13(5):3653-3661. PubMed ID: 28521468
[TBL] [Abstract][Full Text] [Related]
2. Loss of FBXW7 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Enkhbold C; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Ishikawa D; Shimada M
Hepatol Res; 2014 Dec; 44(14):E346-52. PubMed ID: 24552289
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
4. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
5. Low expression of the ubiquitin ligase FBXW7 correlates with poor prognosis of patients with colorectal cancer.
Liu H; Wang K; Fu H; Song J
Int J Clin Exp Pathol; 2018; 11(1):413-419. PubMed ID: 31938126
[TBL] [Abstract][Full Text] [Related]
6. Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.
Ishii N; Araki K; Yokobori T; Gantumur D; Yamanaka T; Altan B; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Hosouchi Y; Kuwano H; Shirabe K
Oncotarget; 2017 Dec; 8(68):112636-112646. PubMed ID: 29348852
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c-Myc and p53 substrates in patients with dysplastic nevi or melanoma.
Mozuraitiene J; Gudleviciene Z; Vincerzevskiene I; Laurinaviciene A; Pamedys J
Oncol Lett; 2021 Jan; 21(1):37. PubMed ID: 33262829
[TBL] [Abstract][Full Text] [Related]
8. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
9. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma.
Li MR; Zhu CC; Ling TL; Zhang YQ; Xu J; Zhao EH; Zhao G
BMC Gastroenterol; 2017 May; 17(1):60. PubMed ID: 28464881
[TBL] [Abstract][Full Text] [Related]
10. FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.
Hagedorn M; Delugin M; Abraldes I; Allain N; Belaud-Rotureau MA; Turmo M; Prigent C; Loiseau H; Bikfalvi A; Javerzat S
Cell Div; 2007 Feb; 2():9. PubMed ID: 17326833
[TBL] [Abstract][Full Text] [Related]
11. C-MYC and Its Main Ubiquitin Ligase, FBXW7, Influence Cell Proliferation and Prognosis in Adult T-cell Leukemia/Lymphoma.
Mihashi Y; Mizoguchi M; Takamatsu Y; Ishitsuka K; Iwasaki H; Koga M; Urabe K; Momosaki S; Sakata T; Kiyomi F; Takeshita M
Am J Surg Pathol; 2017 Aug; 41(8):1139-1149. PubMed ID: 28498285
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of FBXW7 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
Naganawa Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Katada T; Tanaka T; Shiozaki M; Fujii Y; Takeyama H
Exp Ther Med; 2010 Sep; 1(5):841-846. PubMed ID: 22993608
[TBL] [Abstract][Full Text] [Related]
13. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
14. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.
Koga Y; Iwatsuki M; Yamashita K; Kiyozumi Y; Kurashige J; Masuda T; Eto K; Iwagami S; Harada K; Ishimoto T; Baba Y; Yoshida N; Miyanari N; Takamori H; Ajani JA; Baba H
Gastric Cancer; 2019 Nov; 22(6):1100-1108. PubMed ID: 30854619
[TBL] [Abstract][Full Text] [Related]
15. Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis.
Kawashita Y; Morine Y; Ikemoto T; Saito Y; Iwahashi S; Yamada S; Higashijima J; Imura S; Ogawa H; Yagi T; Shimada M
J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):576-583. PubMed ID: 28846828
[TBL] [Abstract][Full Text] [Related]
16. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M
Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810
[TBL] [Abstract][Full Text] [Related]
17. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
18. FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
Yokobori T; Yokoyama Y; Mogi A; Endoh H; Altan B; Kosaka T; Yamaki E; Yajima T; Tomizawa K; Azuma Y; Onozato R; Miyazaki T; Tanaka S; Kuwano H
Mol Cancer Res; 2014 Jan; 12(1):32-7. PubMed ID: 24165483
[TBL] [Abstract][Full Text] [Related]
19. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.
Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M
J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221
[TBL] [Abstract][Full Text] [Related]
20. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
